Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.

• Päätekijät: Feleke Tilahun Zewdu (Tekijä), Asressie Molla Tessema (Tekijä), Aregash Abebayehu Zerga (Tekijä), Saskia van Henten (Tekijä), Saba Maria Lambert (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Public Library of Science (PLoS), 2022-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

<h4>Background</h4>Cutaneous leishmaniasis (CL) is generally caused by Leishmania aethiopica in Ethiopia, and is relatively hard to treat. Sodium stibogluconate (SSG) is the only routinely and widely available antileishmanial treatment, and can be used systemically for severe lesions and...